Skip to content
Screener

D&A at other companies

CVS Health logo
CVS HealthCVS
$1.13B-3.8%
UnitedHealth Group logo
UnitedHealth GroupUNH
$1.03B-3.0%
Astrana Health logo
Astrana HealthASTH
$15.48M+126%
Agilon Health logo
Agilon HealthAGL
$6.86M-6.2%
Clover Health Investments logo
Clover Health InvestmentsCLOV
$515K+10.5%
Aveanna Healthcare Holdings Inc. logo
Aveanna Healthcare Holdings Inc.AVAH
$3.04M+17.3%

Other financials

Income statement

See full
Revenue$251.9M+15.5%
Operating income-$29.1M-186%
Net income-$29.5M-159%
EPS (diluted)-$0.22-175%

Balance sheet

See full
Cash & equivalents$95.5M+58.0%
Total debt$93.8M-11.0%
Total equity$229.0M-3.8%
Total assets$547.4M+2.0%

Cash flow

See full
Operating cash flow$18.1M-26.3%
CapEx$3.6M+24.3%
Free cash flow$14.5M-33.1%

Valuation

See full
Market cap$1.49B+227%
Enterprise value$1.49B+202%
P/S1.6×+1.0×

Profitability

See full
Operating margin-1%-0.4pp
Net margin-1.2%-0.5pp
FCF margin4.5%+2.6pp

Returns & leverage

See full
Return on equity-5%-1.8pp
Debt / equity0.4×0.0×
Current ratio+0.3×

Where this comes from

Reported directly by InnovAge Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The source filing: InnovAge Holdings, Inc.’s 10-Q, filed May 8, 2026.

Filed
May 7, 2026, 8:00 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001834376-26-000022
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025Nine Months Ended March 31, 2026Nine Months Ended March 31, 2025
Cost of care, excluding depreciation and amortization77,67669,499228,448196,947
Sales and marketing8,7446,92224,42821,117
Corporate, general and administrative76,53138,597133,41294,235
Depreciation and amortization4,8245,38614,78616,116
Impairments and loss on assets held for sale1048,495
Total expenses281,022228,300735,284659,893
Operating Loss(29,079)(10,158)(7,528)(27,611)
Other Income (Expense)

Item 1. Financial Statements (Unaudited)

FAQ

What is InnovAge Holdings, Inc.'s D&A?
InnovAge Holdings, Inc. (INNV) reported D&A of $4.82M in Q1 2026.
How has InnovAge Holdings, Inc.'s D&A changed year-over-year?
InnovAge Holdings, Inc.'s D&A decreased by 10.4% year-over-year, from $5.39M to $4.82M.
What is the long-term trend for InnovAge Holdings, Inc.'s D&A?
Over 3 years (2022 to 2025), InnovAge Holdings, Inc.'s D&A has grown at a 11.9% compound annual growth rate (CAGR), from $13.92M to $19.51M.
What does D&A mean?
Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.

Ask your AI about InnovAge Holdings, Inc.'s d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude